Comparative Bioavailability Study of Codeine Sulfate
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to assess the comparative bioavailability of codeine from
Roxane Laboratories' Codeine Sulfate 30mg tablets to Tylenol® #3 (acetaminophen 300mg with
codeine phosphate 30mg) under fasted conditions